Cargando…
Use of Nonrecommended Drugs in Patients With Brugada Syndrome: A Danish Nationwide Cohort Study
BACKGROUND: Patients with Brugada syndrome (BrS) are recommended to avoid drugs that may increase their risk of arrhythmic events. We examined treatment with such drugs in patients with BrS after their diagnosis. METHODS AND RESULTS: All Danish patients diagnosed with BrS (2006–2018) with >12 mon...
Autores principales: | Jespersen, Camilla H. B., Krøll, Johanna, Bhardwaj, Priya, Hansen, Carl Johann, Svane, Jesper, Winkel, Bo G., Jøns, Christian, Jacobsen, Peter Karl, Haarbo, Jens, Nielsen, Jens Cosedis, Johansen, Jens Brock, Philbert, Berit T., Riahi, Sam, Torp‐Pedersen, Christian, Køber, Lars, Hansen, Jacob Tfelt, Weeke, Peter E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122907/ https://www.ncbi.nlm.nih.gov/pubmed/36942759 http://dx.doi.org/10.1161/JAHA.122.028424 |
Ejemplares similares
-
Severity of Brugada syndrome disease manifestation and risk of new-onset depression or anxiety: a Danish nationwide study
por: Jespersen, Camilla H B, et al.
Publicado: (2023) -
Long-term cardiovascular outcomes among immigrants and non-immigrants in cardiac resynchronization therapy: a nationwide study
por: Krøll, Johanna, et al.
Publicado: (2023) -
Correction to: Use of Nonrecommended Drugs in Patients With Brugada Syndrome: A Danish Nationwide Cohort Study
Publicado: (2023) -
Workforce attachment after a congenital long QT syndrome diagnosis: a Danish nationwide study
por: Jespersen, Camilla H B, et al.
Publicado: (2022) -
Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982–2018)
por: Olsen, Thomas, et al.
Publicado: (2019)